DATE
Crinetics Reports Over $5M in Q4 2025 PALSONIFY Revenue with Strong Launch Metrics
Crinetics; PALSONIFY; Palsonify; Q4 2025; revenue; $5M; acromegaly; enrollment forms; prescribers
Novo Nordisk Launches Wegovy Pill in the US with Broad Availability
Novo Nordisk; Wegovy pill; US launch; January 2026; oral GLP-1; weight loss
Biotech’s Groove is Back for 2026: XBI Surges Amid M&A Boom and Lower Rates
biotech; XBI; M&A; lower rates; 2026 trends
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements
Gilead’s $35M Herpes Deal with Assembly Biosciences and Recent FDA Approvals
Gilead; Assembly Biosciences; herpes; HSV; ABI-1179; ABI-5366; FDA; Boehringer; Roche
Spotlight On: Five Key FDA Approvals of 2025
FDA approvals; 2025; orphan drugs; novel therapies; rare diseases
Breakthrough Real-World Evidence Powering Blood Cancer Research in 2025
RWE; blood cancer; real-world evidence; ASH 2025; SOHO 2025; hematologic care
Bayer’s Finerenone Approved in Japan for Chronic Heart Failure Treatment
Finerenone; Kerendia; Japan approval; chronic heart failure; HFmrEF; HFpEF; Bayer; FINEARTS-HF
Biopharma’s Winners and Losers of 2025 – Endpoints News recap
Endpoints News; winners and losers; 2025; biopharma; Post-Hoc Live; Kyle LaHucik; year in review; biotech; pharma; stock movers
No public results for “Take the Biopharma Sentiment Index” Q1 2026 yet
Biopharma Sentiment Index; Q1 2026; biopharma executives; life sciences sentiment; 2026 outlook; M&A activity; AI in biopharma; geopolitical risk; survey data